Hancock Jaffe Laboratories, Inc. (HJLI) Social Stream

Hancock Jaffe Laboratories, Inc. (HJLI): $10.38

0.21 (-1.98%)

POWR Rating

Component Grades








Featured Post From StockTwits About HJLI

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

Market Price - $6.75 (ran 32% since last alert)
Average Hold - $11.20
Accumulate - Sub $6 (raised from sub $5.50)
Price Target - $8.50 (raised from $7.50)
Estimated Time Hold - 1Q
Support - $5.50, $7.50
Floor - $4.99
Double Down Target - Sub $5
Option - N/A
Micro DD - CVI play, approximately 2.4 million people in the U.S. suffer from CVI due to reflux in the deep venous system. Estimates indicate that direct medical costs from CVI in the U.S. exceed $38 billion each year. There are currently no FDA-approved devices or effective treatments for deep venous CVI. Entered Into At--Market Offering Agreement With Ladenburg Thalmann To Create At--Market Equity Program.
Team_Bullish, published August 14, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!